The modulation of the release of noradrenaline (NA) and neuropeptide Y-like
immunoreactivity (NPY-LI) was investigated in the pig kidney in vivo. Under control …

The possible involvement of neuropeptide Y (NPY) in sympathetic control of renal blood flow
was investigated in the pig in vivo. Exogenous NPY caused renal vasoconstriction with a …

The effect of reserpine treatment on renal sympathetic nerve activity and tissue levels of
neuropeptide Y (NPY)‐like immunoreactivity (LI) and noradrenaline (NA) were studied in …

The mechanism underlying the functional effects of neuropeptide Y (NPY)-like
immunoreactivity (LI) and noradrenaline (NA) and their release evoked by nerve stimulation …

This study investigated the effects of BIIE0246, a novel neuropeptide Y (NPY) Y 2 receptor
antagonist, on renal sympathetic nerve-evoked release of noradrenaline and NPY-like …

1. The renovascular effects of neuropeptide‐Y (NPY) were examined in the split
hydronephrotic rat kidney. 2. Systemic infusion of low non‐pressor doses of NPY (0.2 …

1. The effects of neuropeptide‐Y (NPY) on renal function were investigated in conscious
foxhounds. 2. Dose‐response curves (n= 7) were obtained for NPY by measuring renal …

The release of noradrenaline (NA) together with its possible cotransmitter neuropeptide Y
(NPY) was investigated in the perfused dog spleen. The splenic nerve was stimulated …

I. Based on experiments on the rat portal vein, it is suggested that NPY is capable of
inhibiting TNS-induced release of 3H-NA from the sympathetic nerves via a prejunctional …

The effect of neuropeptide Y (NPY) on fractional tritium-noradrenaline (3H-NA) release and
contractile activity was studied in the isolated portal vein of SHR and WKY rats. NPY (5 X 10 …